The anoxemia theory proposes that an imbalance between the demand for and supply of oxygen in the arterial wall is a key factor in the development of atherosclerosis. There is now substantial evidence that there are regions within the atherosclerotic plaque in which profound hypoxia exists; this may fundamentally change the function, metabolism, and responses of many of the cell types found within the developing plaque and whether the plaque will evolve into a stable or unstable phenotype. Hypoxia is characterized in molecular terms by the stabilization of hypoxia-inducible factor (HIF) 1a, a subunit of the heterodimeric nuclear transcriptional factor HIF-1 and a master regulator of oxygen homeostasis. The expression of HIF-1 is localized to perivascular tissues, inflammatory macrophages, and smooth muscle cells adjacent to the necrotic core of atherosclerotic lesions and regulates several genes that are important to vascular function including vascular endothelial growth factor, nitric oxide synthase, endothelin-1, and erythropoietin. This review summarizes the effects of hypoxia on the functions of cells involved in atherogenesis and the evidence for its potential importance from experimental models and clinical studies.
Introduction
Atherosclerosis is a chronic inflammatory process, affecting medium and large arteries and involving lipid deposition, oxidative stress, endothelial damage, and smooth muscle cell (SMC) proliferation and migration. It is associated with several established risk factors, including hypertension, hyperglycemia, aging, and dyslipidemia. 1 There have been a number of hypotheses of atherogenesis, including the anoxemia theory that proposes that an imbalance between the demand for and supply of oxygen in the arterial wall is a key factor in the development of atherosclerosis. 2, 3 The microenvironment within the atherosclerotic plaque is thought to be an important determinant of whether a plaque progresses and the likelihood of clinical complications. It has previously been difficult to investigate cellular metabolism within the artery wall with sufficiently high resolution, and consequently, it has not been possible to identify regions in which extreme hypoxia prevails. However, recent reports do provide substantial evidence that there are regions within the plaque in which hypoxia can be identified. 4 This state of hypoxia has the potential to fundamentally change the function, metabolism, and responses of many of the cell types found within the developing atherosclerotic plaque, and this may in turn determine whether the plaque evolves into a stable or unstable phenotype. It is likely that this is mediated through effects on angiogenesis, extracellular matrix elaboration, and lipoprotein metabolism. The hypoxic milieu in the atherosclerotic plaque may therefore also have implications for the putative therapeutic interventions for atherosclerosis. However, most in vitro studies have been conducted under normoxic conditions. The effects observed under these conditions may not accurately reflect those extant within the plaque.
The Development of a Hypoxic Environment Within the Atherosclerotic Plaque
Hypoxia may be defined as a physiological or pathological state in which the body, or a region of the body, is deprived of adequate oxygen supply at the tissue level to an extent that it is inadequate to meet cellular or tissue demands. Hypoxia may be due to a reduced oxygen supply (due to insufficient blood vessel network or defects in blood vessels) or due to an increased consumption of oxygen relative to the supply (this may result from a rapid increase in cell proliferation). It is usually characterized in molecular terms by the stabilization of hypoxia inducible factor 1a (HIF-1a), a subunit of the heterodimeric nuclear transcriptional factor HIF-1. Hypoxiainducible factor 1, consisting of HIF-1a and HIF-1b subunits, has been described as a master regulator of oxygen homeostasis. Although levels of HIF-1a have been shown to be regulated by nonhypoxic stimuli such as lipopolysaccharides (LPS), thrombin, and angiotensin II (Ang II), 5 it is generally considered to be a biological marker of hypoxia and drives the expression of over 100 genes including those involved in angiogenesis and oxygen transport 6 (see Figure 1  7 ). There are, however, some circumstances under which HIF-1a expression can be prevented. 8 Hypoxia also stabilizes HIF-2a, which is closely related to HIF-1a with respect to its involvement in the transcriptional activation of multiple target genes in hypoxia. 9 In studies using human artery specimens and tissues from experimental animal models of atherosclerosis, HIF-1a has been localized to perivascular tissues, inflammatory macrophages, and SMCs adjacent to the necrotic core of atherosclerotic lesions. In addition to being a marker of hypoxia, HIF-1a may directly enhance atherogenesis through several mechanisms, including SMC proliferation and migration, new vessel formation (angiogenesis), and altered lipid metabolism. Alteration of the HIF-1a pathway has been shown to contribute to vascular graft failure through the formation of intimal hyperplasia in which SMCs from the tunica media (the main muscle layer of the graft vessel) migrate to and proliferate within what is termed the neointima. 10 The HIF-1a has also been implicated in the pathogenesis of atherosclerosis, in-stent restenosis following coronary revascularization, stroke, peripheral artery disease, aortic aneurysm formation, and pulmonary artery hypertension 11 and also appears to be involved in the calcification of blood vessels, which often accompanies atherosclerosis. For example, Li et al have shown that in diabetic patients with a high coronary artery calcium (CAC) score, serum HIF-1a levels were significantly raised and were an independent risk factor for the presence of CAC. Serum HIF-1a levels were positively correlated with other biomarkers of diabetic control and inflammation, such as C-reactive protein (CRP), interleukin-6 (IL-6), HbA1c, fasting blood glucose, and CAC score. The HIF-1a levels were therefore considered to be a significant independent risk factor, predicting the presence of CAC. 12 Although HIF-1 is an intracellular transcription factor, it is possible that it is released into the circulation from damaged cells, as has been reported for other transcriptional factors that include nuclear factor-kappa B (NF-kB) and tumour protein (p53). [12] [13] [14] In healthy medium-sized arteries, the tunica intima (the innermost layer of the artery wall) is a delicate layer consisting of the endothelium, extracellular matrix, and a basement membrane comprising the internal elastic lamina (Figure 2A ). During atherogenesis, the intima may thicken by the accumulation of cells and matrix, and the diffusion of oxygen can then become impaired ( Figure 2B ). Vasa vasorum form a network of small blood vessels lying within the tunica adventitia (the outermost layer of the artery wall). These vessels provide oxygen and nutrients to the wall of the artery. Vasa vasorum are vulnerable to hypoxia especially at the site of arterial branching as they are end arteries and the blood flow is reduced in this region. It has been hypothesized that hypoxia within the vasa vasorum is due to reduced blood flow and consequent endothelial dysfunction, local inflammation, and permeation of large particles such as microbes, LDL-lipoprotein, and fatty acids Figure 1 . Oxygen dependent regulation of the hypoxia-inducible transcription factor (HIF-1a). Under normal oxygen tensions (normoxia), prolyl hydroxylase (PHD) enzymes hydroxylate the HIF-1a subunit resident in the cellular cytoplasm. Hydroxylated HIF-1a facilitates the binding of von Hippel-Lindau protein (pVHL) and subsequent recruitment of the ubiquitin ligase complex (Ubi) leading to HIF-1a proteasomal degradation. Under conditions of reduced oxygen (hypoxia), the lack of oxygen substrate for PHD prevents hydroxylation of HIF-1a leading to its cytoplasmic accumulation and translocation to the cell nucleus. HIF-1a dimerizes with HIF-1b and binds to hypoxia responsive elements (5 0 -ACGTGC-3 0 ) in the promoter of target genes leading to transcription of HIF target genes such as EPO, NOS, and VEGF. EPO indicates erythropoietin; NOS, nitric oxide synthase; VEGF, vascular endothelial growth factor. Adapted from Harris. which are transformed by macrophages into foam cells, 15, 16 which may be an initiating factor in atherosclerosis. The majority of inflammatory cells contributing to early atherosclerosis probably enter the artery wall from the lumen, as shown by the elegant studies of Ross and colleagues. 17, 18 However, the vasa vasorum and associated microvessels may provide an alternate route by which the leukocytes can enter the vascular wall. 19 As atherosclerosis progresses, angiogenic factors within the microenvironment of the plaque may stimulate new vessel formation. The combination of this delicate network of new vessels in juxtaposition to regions rich in inflammatory cells, which elaborate proteolytic enzymes, may contribute to intraplaque hemorrhage and subsequent plaque rupture. 20 The involvement of vasa vasorum and intimal hyperplasia in the pathophysiology of atherosclerosis is supported by several experimental animal studies.
21,22

Evidence for Hypoxia Within Atherosclerotic Plaque
The partial pressure of oxygen (pO 2 ) varies within the artery wall, even in health. The zones of hypoxia within atherosclerotic lesions ( Figure 2B ) may be formed because of impaired oxygen diffusion capacity as the atherosclerotic lesions enlarge but may also be attributable to the high oxygen consumption of macrophage-derived foam cells. 3 Hypoxia has been consistently found in atherosclerotic plaques in vivo in humans and animal models including knock-out mouse models (apolipoprotein E [ApoE À/À ] and the low-density lipoprotein receptor [LDLr À/À ] mice). 23 This has been demonstrated in vivo using various markers, including the chemical 7-(4 0 -(2-nitroimidazole-1-yl)-butyl) theophylline that can be visualized using immunofluorescence. 24 Other noninvasive . Areas of damaged endothelium are partially repaired by endothelial cell precursors (ECP) derived from bone marrow. The HIF-1a is expressed by cells within the hypoxic region within the inner tunica media, and some of this enters the plasma. Within the artery wall, HIF-1a upregulates the expression of erythropoietin (EPO) which has its effects via the EPO receptor (EPOR). The HIF-1a also causes the upregulation of vascular endothelial growth factor (VEGF) and nitric oxide synthase (NOS). IEL indicates internal elastic lamina; EEL, external elastic lamina; EC, endothelial cells of the endothelium; VSMC, vascular smooth muscle cells.
imaging techniques have also been applied that directly target plaque hypoxia, and these techniques are now being further validated in human studies. The metabolic marker Ffluorodeoxyglucose (FDG) has been used to detect human atherosclerosis in vivo 18 and may also serve as an indirect marker of plaque hypoxia as the enhanced glucose uptake in anaerobic metabolism results in an increased uptake of the labeled FDG. 25 Imaging plaque hypoxia could provide a means of assessing putative culprit lesions that are at risk of rupture and are consequentially liable to adverse outcomes. Advanced aortic atherosclerosis was induced in cholesterol-fed rabbits by balloon catheter injury, and F-18-fluoromisonidazole positron emission tomographic was used for the in vivo assessment of hypoxia. This was then related to hypoxia assessed by ex vivo tissue staining using pimonidazole and immunostaining for macrophages (RAM-11), new vessels (CD31), and HIF-1a. Hypoxia was found to be predominantly confined to the macrophage-rich regions within the atheromatous core, whereas the macrophages close to the lumen were hypoxia negative. Intraplaque new vessels were found predominantly in the macrophage-rich hypoxic regions (pimonidazole (þ)/HIF-1a(þ)/RAM-11(þ)). 4 In human studies, this imaging approach has been coupled with quantitative polymerase chain reaction (PCR) and immunostaining of plaque tissues recovered by carotid endarterectomy to determine the gene expression of HIF-1a and cluster of differentiation 68 (CD68, a marker of inflammation). The HIF-1a and CD68 expression were both found to be significantly correlated with F-FDG-uptake, 18 indicating an association between the presence of hypoxia, inflammation, and increased glucose metabolism in vivo. 26 
Consequences of Hypoxia
The HIF is normally only found in hypoxic cells; in normoxia, it is degraded via the proteasome pathway. Prolyl 4-hydroxylases (PHDs) require oxygen for their catalytic activity and function as cellular oxygen sensors, regulating the stability of HIF. In normoxia, 4-hydroxyproline residues are formed at specific sites on the HIF-1a subunit, catalyzed by PHDs, and this leads to its ubiquitination by the von Hippel Lindau E3 ubiquitin ligase and immediate destruction in proteasomes. This prevents the formation of a functional HIF dimer (see Figure 1 27 ). Prolyl 4-hydroxylation is inhibited in hypoxia, facilitating the formation of the HIF dimer and the activation of its target genes, including those for erythropoietin (EPO) and vascular endothelial growth factor (VEGF). It has been proposed that the induction of a pseudohypoxia response by inhibiting HIF PHDs may provide a novel therapeutic target in the treatment of hypoxia-associated diseases. 28 Smallmolecules, such as Roxadustat (FG-4592) 29 and ZYAN1, 30 have been developed to inhibit prolyl hydroxylase domain (PHD)-containing enzymes and cause HIF activation. 31 These agents have been specifically applied to the treatment of renal anemia. 32 They can be administered orally and are associated with an improved iron profile and an endogenous EPO production near the physiological range. They are also likely to be cheaper to manufacture. The clinical trials currently underway will address whether PHD enzyme inhibitors will improve clinical end points, including cardiovascular events. 33 The PHD inhibitors have been reported to reduce blood pressure 32 and plasma cholesterol concentrations. 29 Hence, there is good reason to believe that some PHD inhibitors will reduce cardiovascular end points in patients with renal disease. Whether they will benefit a broader category of patients with high risk of cardiovascular disease is difficult to predict.
The HIF-a subunits are also involved in other key pathways for the adaptation to hypoxia, including VEGF 34 and nitric oxide synthase (NOS). 35 The hypoxia/reoxygenation cycle leads to the formation of reactive oxygen species (ROS) that may subsequently regulate HIF-1 but in a rather complex manner. It has been suggested that ROS promote angiogenesis, either directly via stimulation of HIF-1 genes that are involved in stimulating angiogenesis, such as NOS and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, or via the generation of active oxidation products, including lipid peroxides. The ROS are associated with the development of several chronic diseases that include atherosclerosis, type 2 diabetes mellitus, and cancer (reviewed in Gorlach et al 36 ). The HIF-1a plays a key role in the progression of atherosclerosis by initiating and promoting the formation of foam cells, endothelial cell (EC) dysfunction, apoptosis, increasing inflammation, and angiogenesis. 37 Although ROS have damaging effects on tissues, causing cell death, at high concentrations, lesser degrees of oxidative stress may play a positive role during angiogenesis or other pathophysiological processes. Angiogenesis induced by oxidative stress involves VEGF signaling, although VEGF-independent pathways have also been identified. 38 It has been proposed that the state of hypoxia, present in the atherosclerotic plaques of mice deficient in apolipoprotein E (ApoE À/À mice), may promote lipid synthesis and reduce cholesterol efflux through the ATP-binding cassette transporter (ABCA-1) pathway, processes that are known to be mediated by HIF-1a. 23 Hypoxia has also been reported to increase the formation of lipid droplets in macrophages to promote the secretion of inflammatory mediators and atherosclerotic lesion progression by exacerbating ATP depletion and lactate accumulation in this model of atherosclerosis. 39 Systemic hypoxia that is, for example, associated with obstructive sleep apnea (OSA) also promotes atherosclerosis. The processes by which it may do this include effects on lipid metabolism and efflux, inflammation, altered macrophage polarization, and glucose metabolism. 40 The effect of hypoxia on other mediators will be discussed in the subsequent sections.
Models Used to Assess the Effects of Mediators on HIF-1 Expression In Vitro Models
Endothelial and endothelial progenitor cells. Endothelial dysfunction is one of the first manifestations of atherosclerosis. 41 It is associated with a deficiency of biologically active nitric oxide (NO). 42 After chronic inhibition of endothelial nitric oxide synthase (eNOS), either pharmacologically using N G -Nitro-Larginine methyl ester or using RNA interference, the human umbilical vein endothelial cells (HUVECs) were found to have a higher migratory capability, which was accompanied by an increased expression of VEGF and the VEGF receptor 2 (kinase insert domain receptor [KDR] ). Inhibition of eNOS induced a state of pseudohypoxia (a state under which cells activate a hypoxic response in the presence of oxygen), evidenced by stabilization of HIF-1a. Furthermore, reduced NO expression was associated with significant mitochondrial dysfunction with a consequential decrease in energy production and oxygen consumption. The basal release of NO may act as a negative regulator of HIF-1a levels, and this may have important consequences for EC physiology. 43 The reported effects of NO on HIF-1 expression have been inconsistent. 44, 45 Nitrate and nitrite can be metabolized in vivo to form NO and other bioactive nitrogen oxides, providing an important alternative source of NO during hypoxia when the oxygen-dependent L-arginine-NO pathway may be altered (see Figure 3 ). 46 Nuclear factor-kappa B is a redox-sensitive transcriptional factor. The NF-kB and HIF-1 are both implicated in the expression of proinflammatory cytokines during intermittent hypoxia/ reperfusion (IHR). Intermittent hypoxia/reperfusion is a feature of OSA and an independent risk factor for the development of coronary and cerebral vascular diseases. In vitro studies using EA.hy926 cells (a human vascular EC line) showed that IHR induced the activation of NF-kB and HIF-1, enhanced the messenger RNA (mRNA) expression of proinflammatory cytokines, and increased the activation of p38 mitogen-activated protein kinase (MAPK), which is critical for the production of NF-kB. Propofol (2,6-diisopropylphenol) is a potent intravenous anesthetic agent that attenuates the IHR-induced activation of NF-kB dose dependency. This effect was accompanied by decreased levels of proinflammatory cytokines without changing the activation of HIF-1. This effect is likely to be mediated via the inhibition of the p38 MAPK signaling pathway. Hence, propofol may have the potential to prevent atherosclerosis in patients with OSA by inhibiting NF-kB-mediated inflammation in the vascular endothelium. 47 Endothelin 1 (ET-1) is a potent vasoconstrictor that is predominantly expressed in vascular ECs, as well as by other cells and tissues. Increased plasma levels of ET-1 are associated with atherosclerosis. Hypoxia is one of the most potent inducers of ET-1 gene expression in ECs and may be the primary cause of the increased production of ET-1 during myocardial ischemia. Hypoxia induces the synthesis and secretion of ET-1 in isolated ECs by a mechanism that is antagonized by NO and carbon monoxide and mimicked by transition metals. The induction of ET-1 by hypoxia in vitro has been reported to occur exclusively in early passage ECs where it requires ECspecific factors, new protein synthesis (synthesis inhibited by a protein synthesis inhibitor; cycloheximide), and may involve non-heme oxygen binding enzymes. 48 Intercellular adhesion molecule 1 (ICAM-1) is a cell surface glycoprotein typically expressed in ECs but found as a soluble form (sICAM-1) in plasma. It is thought to be a key molecule involved for the attachment of circulating monocytes to the endothelium and their subsequent transmigration into the intima. Its levels in plasma are related to the severity of atherosclerosis and can predict future cardiovascular events. Increased expression of endothelial ICAM-1 is also related to the chronic effects of oxidative stress. Ziegelstein et al found that when human aortic endothelial cells (HAECs) were exposed to hypoxia/reoxygenation (H/R), hypoxia alone was insufficient to increase either ROS production or ICAM-1 mRNA levels, but a 2.5-fold increase in ICAM-1 mRNA was noted after 30 minutes of reoxygenation. This was not observed in a Ca 2þ -free buffer or in cells treated with an ROS inhibitor, diphenyleneiodonium. Thus, H/R upregulates ICAM-1 mRNA in HAEC via a Ca 2þ -and ROS-dependent mechanism. The characterization of the signaling pathways involved in H/Rinduced adhesion molecule expression may result in a better understanding of the pathobiology of atherosclerosis and of the vascular biology of normal aging. 49, 50 Adenosine monophosphate (AMP)-activated protein kinase (AMPK) is a key enzyme in the regulation of cellular energy and has cardiovascular protective effects. 51 It can detect changes in AMP levels but may also be activated in ECs by an AMPindependent mechanism, involving mitochondrial ROS, generated as a result of the interaction between NO and mitochondrial cytochrome c oxidase at low oxygen concentrations. In hypoxia, a reduction in ATP and the breakdown of ADP to AMP could also activate AMPK. 52 The AMPKa1 is responsible for the expression of genes involved in antioxidant defense, including manganese superoxide dismutase, catalase, g-glutamylcysteine synthase, and thioredoxin. Silencing of AMPKa1 has been reported to cause reduced mitochondrial and eNOS content, reduced cell proliferation, increased accumulation of ROS, and apoptosis. Thus, in HUVECs, AMPKa1 regulates both their mitochondrial content and their antioxidant defenses and is therefore likely to be beneficial in those conditions mediated by oxidative stress and where dysfunction of AMPK may contribute to the initiation and progression of atherosclerosis. 53, 54 Vascular ECs synthesize heparan sulfates. Heparan sulfates expressed on the surface of ECs contribute to their antithrombotic properties by facilitating thrombin inactivation by antithrombin III; this is mediated by the heparin-like sequences within the heparan sulfate chains to which both antithrombin and thrombin may bind. Macrophages are proposed to be a major source of heparan sulfate in atherosclerotic lesion, and this may be modulated by oxygen tension. 55 Furthermore, Karlinsky et al showed that when bovine aortic and pulmonary ECs were cultured under hypoxic conditions (3% oxygen), cell layer-associated heparan sulfate was reduced substantially (>45%). The degradation of heparan sulfate was not affected by hypoxia, however, the percentage of the heparan sulfate that bound to antithrombin III was increased significantly (>33%). The total quantity of heparan sulfates synthesized by the cultured ECs was also affected during exposure to 3% oxygen, but not to the same extent; the authors therefore concluded that hypoxia may differentially influence the chain length and antithrombin III-binding capacity of heparan sulfate species. This would be important in helping to maintain a nonthrombogenic surface under hypoxic conditions, and the hypoxiainduced modification of heparin sulfate may therefore be of relevance to the development of atherosclerotic lesions. 56 Endothelial progenitor cells (EPCs) contribute to vascular repair. They are released into the circulation from the bone marrow and can adhere to the endothelium at sites of injury and hypoxia. 57 They can also contribute to the formation of new vessels following their differentiating into ECs. Apelin is an endogenous ligand for the G protein-coupled receptor APJ, and apelin/APJ signaling appears to be involved in a wide range of physiological and pathological functions in the cardiovascular system. It is also involved in the regulation of EPC proliferation in hypoxic conditions. 58 The HIF-1a promotes the expression of apelin and APJ, which then activate the downstream PI3K/Akt signaling pathway, a key promoter of EPC proliferation. Apelin is therefore proposed to be a novel factor in the development of atherosclerosis. 58, 59 The EPO is a 30 400-Da glycoprotein that regulates red blood cell production. It circulates in plasma and controls the oxygen carrying capacity of the blood. 60 Erythropoietin is produced primarily in the adult kidney and fetal liver. However, it is now well established that several cell types express EPO or its receptor, 61 including vascular smooth muscle 62 and ECs. 63 In these cells, EPO exerts a number of effects including protection against apoptosis, 64 mitogenic, and chemotactic effects (reviewed by Ribatti et al 65 ) . It also stimulates a significant increase in circulating EPCs. Erythropoietin plays an important role in regulating angiogenesis. 66 Although EPO enhances endothelial repair in models of vascular injury, its reported effects on neointima formation in animal models has been inconsistent, with some investigators reporting enhanced neointima formation despite complete re-endothelialization, 67 and others reporting an inhibition of neointima formation that was NO dependent. 68 In human studies, EPO treatment was associated with an increase in neointima generation in patients treated with percutaneous coronary intervention. 69 Furthermore, EPO retards the progression of atherosclerosis. Erythropoietin and one of its nonerythropoeitic analogues (Helix B surface peptide [HBSP]; 30 mg/kg body weight) reduce the cholesterol ester content of aortic tissue in the Watanabe heritable hyperlipidemic (WHHL) rabbits and the intima-media thickness in patients with renal disease undergoing hemodialysis. Erythropoietin (5 U/mL) has been shown to suppress foam cell formation in murine macrophages by promoting the efficacy of cholesterol efflux. [70] [71] [72] Erythropoietin also has protective effects against stress that are related to energy metabolism where it is involved in the regulation of metabolic cell activity, cellular respiration, and mitochondrial function via important energy regulation factors such as AMPK. 73 Tissue hypoxia is the main stimulus of EPO production. Oxygen-dependent regulation of EPO gene expression is controlled primarily by the transcription factor HIF-2a rather than HIF-1a. 74 The response of vascular ECs to EPO is enhanced at a low oxygen concentration (5% or 2%); this has, in particular, been shown for its effect on NO release. Erythropoietin or its receptor is inducible by EPO (5 U/mL) in primary HUVECs and human umbilical endothelial cell artery and cells derived from a transformed human bone marrow microvascular endothelial line (TrHBMEC).
Hypoxia can also induce the mobilization of EPCs via a NADPH oxidase (Nox2)-dependent pathway. The Nox2 is an important source of ROS. This response is abolished in Nox2 knockout mice Nox2(y/-). The EPO is also known to induce EPC mobilization and this too appears to be Nox2 dependent. The ROS are the products of the enzymatic reaction catalyzed by Nox2, and EPO was found to increase ROS production and the migration and proliferation of EPCs derived from WT mice, but no increase of ROS formation was observed in Nox2-deficient EPCs. Furthermore, re-endothelialization of the injured mouse's carotid artery was enhanced by hypoxia, or EPO, and this effect was not observed in Nox2(y/-) mice or after transplantation of Nox2(y/-) bone marrow cells. Overexpression of the EPO receptor can increase EPO-dependent signaling. Ligand-induced EPO receptor dimerization allows binding of Janus kinase 2 (Jak2). The JAK2 then creates Src Homology 2 (SH2)-binding sites by phosphorylating tyrosine residues on the EPO receptor. Phosphorylation of the receptor activates Rac1 and PI3K, which in turn leads to the assembly of Nox2-containing NADPH oxidase that subsequently synthesize superoxide anions. The signal transducers and activators of transcription 5 (STAT5) also binds to the SH2 domains of the EPO receptor, where it is phosphorylated, dimerizes, and eventually translocates to the nucleus. It then initiates the transcription of several target genes and leads to cell proliferation, migration, and mobilization. In the absence of ROS production by Nox2, STAT5 is dephosphorylated before STAT5-mediated signaling can occur. Small interfering RNA against the redoxsensitive phosphatase SHP-2 restored EPO-mediated STAT5 induction, and inhibition of SHP-2 restored EPO-induced migration in Nox2-deficient cells. It therefore appears that Nox2-derived ROS inactivate SHP-2 and thereby facilitate EPO signaling in EPCs to promote hypoxia-induced mobilization and vascular repair by these cells. 75 Endothelial cells release ATP in response to changes in blood flow (producing shear stress), or hypoxia, where it acts on ATP receptors (P2X and P2Y) on the ECs to produce NO, prostacyclin (PGI2) and endothelium-derived hyperpolarizing factor, which contribute to blood vessel dilatation. ATP is also released from sensory-motor nerves during antidromic reflex activity to produce relaxation of some blood vessels. The purine and pyrimidine nucleosides and nucleotides have long-term (trophic) actions in promoting migration and proliferation of both vascular smooth muscle and ECs via adenosine receptor (P1) and ATP receptors (P2Y) during angiogenesis and vessel remodeling during restenosis after angioplasty. 76, 77 Endothelial cells express receptors for very low-density lipoprotein (VLDLr). In addition to their function as peripheral lipoprotein receptors, VLDLrs have other possible biological roles including in signal transduction, angiogenesis, and tumor growth. Some recent studies suggest that the VLDLr has a regulatory role in endothelial pathology. The activation of retinal vascular ECs and promotion of angiogenesis are mediated through the VLDLr. Hypoxia can trigger endothelial endoplasmic reticulum (ER) stress and apoptosis and induce the expression of VLDLr through the interaction of HIF-1a with the hypoxia responsive element (HRE) at the VLDLr promoter. The VLDLr then mediates the ER stress response and apoptosis. 78 High-density lipoproteins (HDLs) are thought to be involved to reverse cholesterol transport (RCT; transporting cholesterol from peripheral tissue back to the liver) and have therefore been proposed to have a protective role in atherosclerosis. 79 The
HDLs also appear to promote hypoxia-induced angiogenesis. 80 In hypoxia, recombinant HDL augments the HIF-1/VEGF pathway via scavenger receptor class B type 1, leading to the modulation of the posttranslational regulators of HIF-1 (PI3K/Siahs/ PHDs), crucial mediators in angiogenesis. Despite strong epidemiological and preclinical evidence for the atheroprotective effects of HDL, recent HDL-raising clinical trials have been unable to show cardiovascular benefits. 80 Augmentation of angiogenesis and the HIF-1/VEGF pathway in hypoxia may have important implications for the targeting of HDL-raising therapies, particularly for the prevention of ischemic injury after myocardial infarction. 81 The CD40 and its ligand (CD40L) have been implicated in the pathogenesis of atherosclerosis; the interaction between CD40 and CD40L is involved in the activation of antigenpresenting cells (APCs), such as macrophages. This interaction modulates the generation of endothelial ROS. It has been found that hypoxia enhances the inflammatory effect of CD40L in both human endothelial and monocytic cells (THP1) and induces ROS production, the synthesis of Intercellular Adhesion Molecule 1 (ICAM1), and activates stress response proteins (p38 MAPK and HSP27), indicating that CD40L mediates the induction of oxidative stress in these cells. The interaction between CD40-CD40L is augmented in hypoxia playing a potentially important role in vascular inflammation, cellular adhesion, and angiogenesis, processes involved in atherosclerosis. 82 The retinoic acid-related orphan receptor a (RORa) is involved in regulating inflammatory and immune responses and lipid metabolism. The RORa mRNA has been detected in ECs and SMCs. Its expression is significantly decreased in atherosclerotic plaques. Plasma and intracellular levels of cholesterol may be important in the regulation of the transcriptional activity for RORa. Hypoxic conditions induce the expression of RORa, and when cells were treated with RORa, the transcriptional activity of HIF-1a was enhanced. The RORa was reported to be physically associated with HIF-1a via its DNA-binding domain, and this was required for the RORa-induced stabilization and transcriptional activation of HIF-1a. In vitro ROR ligands enhance the formation of capillary tubes by human umbilical vascular ECs suggesting a potential involvement of ROR and its ligands in the major clinical end points associated with atherosclerosis. 83, 84 Atherosclerosis is associated with decreased endothelial NO production. Nitric oxide normally reduces cellular oxygen consumption by competitively inhibiting cytochrome c oxidase. Endothelial NO can therefore modulate O 2 consumption in conductance vessels and the microcirculation and appears to regulate O 2 distribution to the surrounding tissues. Removal of NO abolishes this regulatory function. Hence, endothelial NO plays a major role in facilitating the distribution of O 2 , which is crucial for the adaptation of tissues, including the vessel wall itself, to hypoxia. [85] [86] [87] Vascular SMCs. Smooth muscle cell proliferation is increased in pathological conditions, including atherosclerosis, resulting in the thickening of the vessel walls. 88 The migration of vascular smooth muscle cells (VSMCs) from the tunica media to the intima and their proliferation under the influence of growth factors such as platelet-derived growth factor are critical steps in atherogenesis. 89 The proliferation and migration of VSMCs is also involved in new vessel formation (angiogenesis), and this is coordinated by a number of factors that include VEGF. 90 The VEGF is a hypoxia-inducible angiogenic factor. It also mediates the angiogenic effects of other growth factors that are not themselves direct EC mitogens. Exposure of VSMCs to a threshold hypoxic stimulus (2.5% O 2 ) causes a modest increase in VEGF mRNA levels. These effects of hypoxia are synergistic with basic fibroblast growth factor (bFGF), which also plays a role in inducing angiogenesis. This synergistic effect on VEGF expression appears to be specific as hypoxia has not been found to enhance the bFGF-induced expression of the proto-oncogene c-myc (the gene responsible for cell proliferation). The bFGF may therefore promote angiogenesis both by a direct effect on ECs and indirectly by the upregulation of VEGF in VSMCs. The synergy demonstrated between hypoxia and bFGF suggests that multiple diverse stimuli may interact via the upregulation of VEGF expression in VSMCs to amplify the angiogenic response. 91 The increased expression of VEGF following exposure to hypoxia is also enhanced by platelet-derived growth factor-BB (PDGF-BB). The synergy between hypoxia and PDGF-BB was again found to be selective for VEGF expression as hypoxia had no effect on the PDGF-induced upregulation of the proto-oncogene c-myc. 92 Moderate hypoxia (5% O 2 ) has also been reported to enhance the proliferative responses of human pulmonary artery SMC to mitogens including PDGF, bFGF, and epidermal growth factor (EGF). Moderate hypoxia also elicited increased cellular HIF-1a levels and enhanced PDGF-, bFGF-, and EGF-induced expression of HIF-1a. These effects were abrogated by the knocking down of HIF-1a using specific small interfering RNAs, but this failed to inhibit the co-mitogenic effect of hypoxia. Hence, HIF-1a promotes proliferative responses of human VSMC to bFGF, PDGF, and EGF by mechanisms that may involve HIF-1-dependent expression of cyclin A, but HIF is apparently not crucial to the enhancement of bFGF, PDGF, and EGF-induced proliferation of VSMC that occurs during hypoxia. 93 Hypoxia increases cytosolic calcium concentration, enhances prostaglandin (PG) release and synthesis of platelet-activating factor in ECs, and increases neutrophil adherence. Hypoxia may also change the balance between EC-derived growth inhibitors and activators for SMCs, shifting it to a more pro-proliferative activity, which could explain the proliferation of SMCs observed in vivo in some pathological conditions, such as atherosclerosis. Michiels et al investigated the influence of hypoxic EC-conditioned media on SMC proliferation. The HUVECs exposed to hypoxia, elaborate mitogenic factors that had a pro-proliferative effect on SMC that was not inhibited if the HUVECs were treated with the protein synthesis inhibitor, cycloheximide, but was blocked if PGs synthesis was inhibited during hypoxia. Therefore, it appears that PGs and bFGF are responsible for this pro-proliferative activity, and their effect is additive. 88 Proteoglycan are important constituents of the arterial wall extracellular matrix and participate in normal vascular homeostasis and function, as well as in the trapping and modification of serum-derived lipoproteins. The majority of proteoglycans in the artery wall are produced by vascular ECs and SMCs. The proteoglycans secreted by SMC cultures exposed to hypoxia/ reoxygenation are increased substantially compared to cells exposed to continuous normoxia. The newly synthesized proteoglycans synthesized by SMCs exposed to either condition did not differ in their charge densities or molecular weight but did differ in glycosaminoglycan (GAG) composition. In the cells exposed to hypoxia/reoxygenation, there was a 60% increase in a proteoglycan subfraction that bound LDL with very high affinity. Hypoxia followed by reoxygenation is perhaps a more important signal for SMC changes, including induction of synthesis of a proteoglycan species with very high affinity binding for plasma LDL. 94 Human coronary artery smooth muscle cells (CASMCs) cultured under hypoxic conditions (1% O 2 , 5% CO 2 ) have been found to express increased levels of VEGF, VEGF receptor 1 (VEGFR-1), and HIF-1a. Hypoxia was associated with enhanced [H3]-thymidine incorporation, which was completely inhibited by a neutralizing antibody against VEGF and attenuated by a neutralizing antibody against NADPHcytochrome P-450 reductase (NPR), which contributes to the stabilization of HIF-1a. The effects of hypoxia were also attenuated in NPR-knockdown cells and enhanced in NPRoverexpressing cells. Hypoxia-induced proliferation of CASMCs is mediated by an increased expression of VEGF and VEGFR-1, acting via an autocrine mechanism. The expression of these 2 molecules is dependent on the stabilization of HIF1a, which is regulated by NPR. It has therefore been suggested that hypoxia and NPR are implicated in the pathogenesis of progressive atherosclerosis. 95 Thrombospondin 1 (TSP-1) is also associated with the formation of atherosclerotic lesions, acute vascular injury, hypercholesterolemia, and hypertension. The administration of antibodies against TSP-1 has been shown to significantly accelerate re-endothelialization and reduce neointima formation in balloon-injured rat arteries. The TSP-1 has been reported to be a potent inducer of the migration of bovine pulmonary artery SMCs and human VSMCs. When human CASMCs were cultured under hypoxic conditions, mRNA and protein levels of TSP-1, and mRNA levels of integrin b(3) were increased with the increase in HIF-1a protein. The DNA synthesis and migration of the cells were stimulated under these conditions, and a neutralizing anti-TSP-1 antibody apparently suppressed the migration, but not DNA synthesis. The migration was also inhibited by the tripeptide Arg-Gly-Asp (RGD) that binds to integrin b(3). Furthermore, the migration was completely suppressed in HIF-1a-knockdown cells exposed to hypoxia and enhanced in HIF-1a-overexpressing cells. These results suggest that hypoxia enhances the migration of CASMCs and that the migration is elicited by TSP-1, the induction of which is dependent on the stabilization of HIF-1a. 96 Macrophage migration inhibitory factor (MIF) has emerged as a key factor in vascular remodeling and in the development and progression of atherosclerosis. The MIF is an essential, upstream component of the inflammatory cascade and has a critical role in several inflammatory conditions. It can be expressed by vascular ECs, VSMCs, and macrophages. Increased expression of vascular MIF is associated with foam cell transformation during atherogenesis. The MIF is expressed in atherosclerotic lesions, and it has been suggested to be involved in atherosclerotic plaque development. Several proatherosclerotic mediators such as oxidized LDL, CD40-L, and ANG II are able to stimulate MIF expression. The MIF mRNA and protein were found to be upregulated early after exposure to moderate hypoxia (3% O 2 ) in cultured human VSMCs. This is HIF-1a dependent, as knockdown of HIF-1a was found to inhibit the hypoxia-induced induction of MIF gene and protein expression. This upregulation of MIF was attenuated by antioxidant treatment and by inhibition of extracellular signal-regulated kinase (ERK). Under moderate hypoxia (3% O 2 ), both cell proliferation and cell migration were increased in VSMC cells. Blocking the MIF by specific small interference RNA to MIF (MIF-shRNA) resulted in the suppression of proliferation and migration of VSMCs. 97 Leptin is an adipose tissue-derived hormone involved in weight regulation. 98 Leptin has now been reported to be hypoxia inducible 99 and may be involved in the pathogenesis of atherosclerosis by initiating leukocyte and macrophage recruitment to the endothelium. 100 Leptin also has several other proatherogenic properties; it stimulates the proliferation of VSMCs and their production of metalloproteinase. In addition, leptin promotes the production of proliferative and inflammatory cytokines, it increases platelet aggregation, and enhances the secretion of proatherogenic lipoprotein lipase by cultured human and rodent macrophages causing endothelial dysfunction through the induction of AngII, ROS, and the JNK pathway. 101 An adverse intrauterine environment during a critical period in fetal development may increase subsequent risk of cardiovascular disease in adulthood. 102 Chronic hypoxia during gestation is considered to be one of the most common intrauterine stressors, and Lv et al showed that exposure of neonatal rat aorta SMCs to 2% oxygen enhanced their proliferation in a time-dependent manner and decreased their rate of apoptosis. This was associated with reduced levels of the proapoptotic proteins, BNIP3 and bax, and an increase in the antiapoptotic factor B-cell lymphoma 2 (Bcl-2) under hypoxic conditions. Specific downregulation of HIF-1a partly abolished the proliferative effect of hypoxia. 103 Dipeptidyl peptidase 4 (DPP4) is a 110-kDa glycoprotein expressed on several cell types and the expression of which is upregulated following exposure to moderate hypoxia (3% O 2 ). Matrix metalloproteinase (MMP)-1, -2, and 14 are involved in the shedding of DPP4 from human VSMCs both constitutively and under hypoxic conditions. It has been reported that increased DPP4 shedding from SMC occurs due to a complex interplay between different MMPs in cell type-specific manner 104, 105 and that DPP-4 inhibitors, such as alogliptin have anti-atherosclerotic properties. 106 Obstructive sleep apnea is characterized by intermittent hypoxia (IH) and is associated with an increased risk of cardiovascular disease. Intermittent hypoxia induces VSMC proliferation, possibly mediated in part by members of the EGF family, such as epiregulin, amphiregulin, and neuregulin-1, and the EGF receptor (erbB2) may be involved in the IH-induced VSMC proliferation. 107 Intermittent hypoxia induces the expression of HIF-1-dependent genes, including VEGF and NF-kB as well as the release of ROS. 108 However, there is still debate as to whether HIF-1a is activated during OSA and IH.
Low-density lipoprotein receptor-related protein (LRP1, also termed the Apolipoprotein E[ApoE] receptor) plays an important role in lipoprotein metabolism and vascular function. In VSMCs exposed to hypoxia (1% O 2 ), there was a timedependent induction of LRP1 mRNA and protein expression, with maximum levels being observed at 12 to 24 hours following exposure. This effect was mediated by HIF-1a and was found to result in increased cholesteryl ester (CE) accumulation due to an increased uptake of modified (aggregated) lowdensity lipoprotein (agLDL). Blockade of HIF-1a expression inhibited the upregulatory effect of hypoxia on LRP1 expression and agLDL-derived intracellular CE accumulation, suggesting that both LRP1 overexpression and increased CE accumulation in hypoxic VSMCs are dependent on HIF-1a. 109 Resistin is a cysteine-rich adipose-derived peptide hormone that in humans is encoded by the RETN gene. 110 It produces proinflammatory effects in the vascular wall. 111, 112 It promotes EC activation and causes endothelial dysfunction of porcine coronary arteries. Resistin was reported to have a potential proatherogenic effect by increasing the expression of proinflammatory cytokines in vascular ECs and through its promotion of VSMC proliferation. Hypoxia significantly increases the expression of resistin protein and mRNA in rat aortic SMCs. The specific ERK inhibitor PD98059, antioxidant N-acetylcysteine, and ERK siRNA all attenuated the induction of resistin protein by hypoxia. Resistin also increases ROS production that could be blocked by pretreatment with N-acetylcysteine. Hence, it appears that the hypoxia-induced increase in resistin is mediated through ROS, ERK, MAPK, and nuclear factor of activating T cell pathway. 113 Monocyte/macrophage. Angiogenesis is increased in lipid-rich plaque. Oxidized low-density lipoprotein (ox-LDL) is generated in lipid-rich plaque by oxidative stress. It triggers an inflammatory response to cause endothelial dysfunction. However, ox-LDL can activate HIF-1a in monocytes in a hypoxiaindependent manner. It has been hypothesized that HIF-1a activation in monocyte macrophages could transmit proangiogenic effects of ox-LDL linking hyperlipidemia, inflammation, and angiogenesis in atherosclerosis. The ox-LDL has been reported to strongly induce HIF-1a and VEGF in monocytemacrophages and increase endothelial tube formation in cocultured ECs. The HIF-1a inhibition reversed this effect. There was a direct proangiogenic effect of ox-LDL in an in vivo angiogenesis assay. Again, HIF-1a inhibition abrogated the proangiogenic effect of ox-LDL. In a rabbit model, administration of a low-lipid diet significantly reduced the expression of both HIF-1a and VEGF, resulting in decreased plaque neovascularization. 114 The ox-LDL appears to be a proangiogenic agent linking hyperlipidemia, inflammation, and angiogenesis in atherosclerosis. Hence, this effect is dependent on macrophages and on the induction of the HIF-1a pathway converting monocyte macrophages into potent proangiogenic cells. This mechanism could underlie the previously reported property of ox-LDL as a marker of atherosclerosis progression in patients with coronary artery disease. 114 Monocytes migrate from the circulating blood where the oxygen tension is high to the arterial wall where the oxygen tension is low. This change in the microenvironmental oxygen concentration may affect the metabolism of LDL by the monocyte-derived macrophage. Although the specific binding and association of LDL are not changed by hypoxia, the degradation of LDL is reduced to 60% of its rate in normoxia, and the rates of cholesterol esterification and cellular accumulation are increased. The secretion of ApoE is not altered under hypoxia, and therefore, it is likely that ApoE-independent cholesterol efflux is reduced. Therefore, hypoxia affects the intracellular metabolism of LDL, stimulates cholesterol esterification, and enhances CE accumulation in macrophages. 115 Transmigration of monocyte-derived macrophages into the subendothelial space is also a crucial step in atherogenesis. Proinflammatory macrophages ingest ox-LDL via scavenger receptors and become foam cells, thereby promoting plaque formation. Foam cell formation is a key event in both early and late atherosclerotic lesions. 18 Although a number of proteins may contribute to this process, scavenger receptors A (SRA), lectin-like ox-LDL receptor (Lox-1), and cluster of differentiation 36 (CD36) have been demonstrated to be the most relevant for cholesterol uptake. 116 The mRNA and protein expression of SRA and CD36 are upregulated by ox-LDL but are decreased following exposure of macrophages to hypoxia. 117 In contrast, Lox-1 mRNA and protein levels were shown to be upregulated under hypoxic conditions. 117 In this study, it was also shown that there was an increase in the lipid content of macrophages after exposure to 0.2% oxygen or treatment with the hypoxia-mimetic dimethyloxalylglycine. Blocking of the Lox-1 receptor decreased the hypoxic induction of ox-LDL uptake and lipid content of macrophages. The RNAimediated knockdown of HIF-1a in macrophages was found to attenuate the hypoxic induction of Lox-1. Hence, hypoxia increases the lipid uptake by macrophages and differentially regulates the expression of ox-LDL receptors. The Lox-1 plays a major role in hypoxia-induced foam cell formation which is, at least in part, mediated by HIF-1a. It has been proposed that HIF-1a is involved in Lox-1 upregulation, thereby enhancing ox-LDL uptake. 117 Furthermore, Burke et al showed that RNA interference for HIF-1a (HIF-1a-siRNA) inhibited foam cell formation in the human monoblastic cell line (U937) treated with ox-LDL, while several atherosclerosis-related genes, such as cyclooxygenase-2 (COX-2), vascular cell adhesion molecule 1, and IL-1b were downregulated. Hence, the induction of HIF1a by atherogenic factors may be involved in coordinating the cellular events that culminate in the formation of atherosclerotic lesions. 118 The ATP-binding cassette transporter A1 (ABCA1) plays an important role in RCT, a process that is involved in atherogenesis. During atherogenesis, lipid-loaded macrophages are exposed to regions of local hypoxia that may influence RCT and affect the lipid efflux of macrophages in the arterial wall. The HIF-1 binds to the HRE region of the ABCA1 promoter, and the HIF-1 complex increases ABCA1 promoter activity and ABCA1 expression. Primary human macrophages exposed to hypoxia or constitutively expressing active HIF-1a have been found to respond with a potent change in ABCA1 expression, which shows a strong correlation with HIF-1b expression. Furthermore, ABCA1-mediated cholesterol efflux was found to be regulated by HIF-1b under hypoxia. In vivo, in macrophages prepared from human atherosclerotic lesions, HIF-1b acted as a major regulator of ABCA1 expression under hypoxia. The HIF-1b availability could therefore determine ABCA1 expression and cholesterol efflux in macrophages under hypoxia. 119 The AMPK was initially identified as the kinase that phosphorylates 3-hydroxy 3-methylglutaryl coenzyme A reductase (the rate-limiting enzyme for cholesterol biosynthesis). The AMPK is activated by increased concentration of AMP. Hypoxia stimulates AMPK in activated monocytes. Stimulation of macrophages with the anti-inflammatory cytokines IL-10 and transforming growth factor b resulted in the rapid phosphorylation of AMPK, whereas stimulation of macrophages with lipopolysaccharide resulted in AMPK dephosphorylation and inactivation. The AMPK directs signaling in macrophages in a way that suppresses proinflammatory responses and promotes macrophage polarization to an anti-inflammatory functional (M2) phenotype. 120 Several mechanisms are involved in controlling monocyte and macrophage motility in response to hypoxia. Chemokinesis (the motility of cells) is enhanced in human monocyte derived macrophages (HMDM) after 24-hour exposure to low O 2 tension (0.5%) compared to cells grown under normoxia. Cell surface heparan sulfate proteoglycan (HSPG) bind cytokines, chemokines, and growth factors and regulate a wide variety of biological activities, including cell migration, cell adhesion, proliferation, receptor interaction, coagulation, and lipoprotein binding and uptake. Macrophages appear to play a role in the synthesis of cell membrane HSPG associated with CVD. There are 2 types of cell membranes, namely, HSPG, the transmembrane syndecans, and the GPI-anchored glypicans. Human monocyte-derived macrophage exposed to hypoxia for 24 hours had a lower mRNA expression of syndecan-1 and -4 compared with cells exposed to normal cell culture conditions. Protein levels of syndecan-1 were also decreased significantly, and cells exposed to hypoxia had lower mRNA expression for key enzymes involved in HS biosynthesis. 55 A critical step in the development of atherosclerotic plaques appears to be the retention of apoB-100-containing lipoproteins in the arterial wall, and this is partially mediated by the interaction between positively charged regions of apoB-100 and the negatively charged GAG chains of proteoglycans (PG) in the intima. Macrophages secrete PG, such as versican, that can alter the retention of lipoproteins and the activity of enzymes, cytokines, and growth factors involved in atherogenesis. They can secrete other PG including perlecan and serglycin and macrophage colony-stimulating factor. Versican has been found to be colocalized with HIF-1a in macrophage-rich areas in human advanced atherosclerotic lesions. In vitro, versican and perlecan mRNA expression increased after exposure to hypoxia. Furthermore, siRNA knockdown of HIF-1a and HIF-2a in the THP-1 cell line showed that hypoxia-induced versican and perlecan mRNA expression were inhibited, and this was mediated via HIF signaling. Versican expression was coregulated by HIF-1a and HIF-2a, but expression of perlecan was influenced only by HIF-1a. Hence, oxygen concentration is an important modulator of PG expression in macrophages, partially explaining the proatherogenic role of macrophages in atherosclerotic lesions. 121 Furthermore, the secreted GAGs from HMDM exposed to hypoxia were longer, more sulfated, and had a higher affinity for LDL compared to those produced under normoxia. These results indicate that hypoxia induced changes in macrophage GAG biosynthesis, which have important consequences for the interaction with LDL and may contribute to the development of atherosclerosis in the hypoxic intima. 122 Within inflamed tissues such as atherosclerotic plaques, macrophages are chronically exposed to hypoxic conditions. In stress conditions, such as those associated with inflammation, Akt regulates several signaling pathways and mediates cell survival. Macrophages also express MMPs that promote matrix remodeling and atherosclerotic plaque instability. Although moderate hypoxia (approximately 2% to 5% O 2 ) does not affect macrophage differentiation (assessed by scavenger receptor expression), it was found to be associated with activated Akt and inactivated glycogen synthase kinase (GSK) 3 (a negative effector of Akt), allowing nuclear translocation of b-catenin. Catenin is a transcriptional factor that plays a critical role in a variety of cell processes including angiogenesis. Hypoxia was associated with an induction of mRNA expression of the b-catenin-associated genes, including, MMP-7, CD44, and c-Myc. The RNAi of TCF7L2, a cofactor of b-catenin, was found to suppress MMP-7 expression induced by hypoxia. Inhibition of Akt phosphorylation by the PI3 kinase inhibitor, LY294002, abolished hypoxia-induced GSK-3 b inactivation, b-catenin activation, and MMP-7 expression. Macrophages under hypoxia were found to be more resistant to ox-LDL-induced apoptosis. Therefore, the induction of macrophage products in chronically hypoxic tissues such as atherosclerotic plaques and adipose tissue may further amplify the proinflammatory milieu within these tissues. 123 Toll-like receptors (TLRs) play an important role in triggering immune and inflammatory responses by detecting invading microbial pathogens and endogenous danger signals. They elicit both potentially protective and detrimental effects in atherosclerosis where the outcome of TLR signaling is dependent on the agonist and responding cell type. 124 Increased expression of TLR4 is implicated in exacerbating the inflammatory responses in ischemic tissue injury and chronic diseases. The TLR4 expression is upregulated by hypoxic stress mediated by HIF-1a in macrophages. The PI3K/Akt was shown to be necessary for HIF-1a stabilization on the early stage of hypoxia through inhibition of GSK-3b. Treatment with pharmacological inhibitors of PI3K and Akt, or knockdown of Akt expression by siRNA, was found to block the increase in TLR4 mRNA and protein levels in macrophages exposed to hypoxia. Phosphorylation of Akt by hypoxic stress preceded the nuclear accumulation of HIF-1a. The HIF-1a-mediated upregulation of TLR4 expression was blocked by LY294002. Furthermore, the antioxidant, sulforaphane (SFN) suppressed hypoxia-induced upregulation of TLR4 mRNA and protein by inhibiting PI3K/ Akt activation and the subsequent nuclear accumulation and transcriptional activation of HIF-1a. However, p38 was not involved in HIF-1a activation and TLR4 expression induced by hypoxic stress in macrophages. These data indicate that PI3K/Akt contributes to the hypoxia-induced increase in TLR4 expression in macrophages at least partly through the regulation of HIF-1 activation and that SFN contributes to protection against ischemic tissue injury by downregulation of TLR4 expression in macrophages. 125 Inflammation is involved in all phases of atherogenesis, and proinflammatory cytokines and chemokines secreted from the immune cells involved in the inflammatory response are involved in the progression of the atherosclerotic process. 126 Among the cytokines that have received particular attention are IL-1a and IL-1b. 127 Hypoxia enhances pro-IL-1 b protein but not mRNA expression in LPS-stimulated human macrophages. It also retards the autophagic degradation of pro-IL-1b and thus prolongs its effective half-life, promoting its intracellular accumulation. Furthermore, hypoxia increases the expression of NLRP3 and augments caspase-1 activation in LPS-primed macrophages. Consequently, human macrophages exposed to hypoxia secrete increased levels of mature IL-1b compared to normoxic macrophages after treatment with crystalline cholesterol. In human atherosclerotic plaques, derived from carotid endarterectomy specimens, IL-1b was localized predominantly in macrophage-rich regions that also express activated caspase-1 and the hypoxia markers HIF-1a and hexokinase-2. Hence, hypoxia appears to potentiate the expression of IL-1 b in the context of atheroma. 128 The link between macrophage glycolysis and their proinflammatory activity is probably mediated by HIF-1a and the transcriptional induction of 6-phosphofructo-2 kinase, 2,6-biphosphatase (PFKFB3). Tawakol et al showed that hypoxia could potentiate macrophage glycolytic flux and a proportional upregulation of proinflammatory activity, that is dependent on both HIF-1a and PFKFB3. 129 In macrophages exposed to hypoxia, there is an upregulation of several genes, including, VEGF, the glucose transporter 1 (GLUT1), MMP-7, neuromedin B receptor, and the DNAbinding protein inhibitor. These genes may be important for the survival and functioning of macrophages in hypoxic diseased tissues. 130 Other immune cells are found within atherosclerotic lesions, namely, dendritic cells (DCs) and T cells and are also proposed to contribute to atherogenesis. 126 Dendritic cells can be found in healthy arterial vessels but accumulate especially in the areas of atherosclerotic plaque. In atherosclerosis, DCs are thought to play an important role in controlling cell recruitment, migration, lipid uptake, and T-cell responses. Hypoxia, ox-LDL, tumor necrosis factor a, and inhibition of endothelial NO synthase may all augment adhesion of DC to the endothelium where HIF-1 triggers DC activation. 131, 132 The miRNAs are a class of endogenous small RNAs that act as inhibitors of posttranslational gene expression or promote RNA degradation by duplex formation within the 3 0 -untranslated region (UTR) of target mRNAs. They play an important role during a wide range of cellular processes by fine-tuning gene expression. 133 Monocytes migrate from the circulation, where the oxygen tension is high, into areas with a high inflammation, such as the atherosclerotic plaque. There, they differentiate into macrophages. During this process, there is a change in the expression pattern of the HIF-1a and HIF-2a genes. This is associated with a downregulation of microRNAs encoded by the miR-17-92 cluster. The miRNAs from the miR-17-92 cluster (mi-17 and -20a) can regulate HIF-1a and HIF-2a by targeting their 3 0 -UTR. These miRNAs are repressed during the differentiation of monocytes into macrophages. The miRoverexpression in human macrophages demonstrates the important role of this microRNA-mediated regulation of the HIF-system for adaption of macrophages to hypoxia. The HIF-system is activated during the differentiation of monocyte into macrophages. This activation is in part mediated by a miRNA-dependent mechanism, which seems to be crucial for the adaption of macrophages to hypoxia. 134 
Animal Models Rodent Models
Altering HIF-1 expression. The HIF-1a is the regulatory subunit of a transcriptional complex, which controls the recruitment of multipotent progenitor cells and tissue repair in ischemic tissue by inducing stromal cell-derived factor (SDF)-1a expression. In VSMCs, HIF-1a can be activated under normoxic conditions by platelet products. Previous studies have investigated the effect of altering the local expression of HIF on atherosclerotic plaque development in murine vascular injury models.
The expression of HIF-1a has been investigated in a wireinduced vascular injury model in the hyperlipidemic ApoE (À/À) mice. In this model, HIF-1a expression was increased in the tunica media, predominantly in the SMCs, as early as 1 day after injury. Nuclear translocation of HIF-1a and colocalization with stromal cell derived factor (SDF-1a, a proinflammatory chemokine upregulated in injured vessels and responsible for cell migration and recruitment of new smooth muscle progenitor cells) was detected in neointimal cells after 2 weeks. The HIF-1a mRNA expression was induced at 6 hours after injury as determined by real-time reverse transcription polymerase chain reaction (RT-PCR). Inhibition of HIF-1a expression by local application of HIF-1a-siRNA reduced the neointimal area by 49% and significantly decreased the neointimal SMCs content compared to treatment with the controlsiRNA. The expressions of HIF-1a and SDF-1a were reduced in neointimal cells of the HIF-1a-siRNA-treated arteries. The HIF-1a expression therefore appears to be directly involved in the formation of the neointima after vascular injury and mediates the upregulation of SDF-1a, which may affect the stem cell-dependent repair of injured arteries. 135 In experiments in which the local expression of the different HIF-subunits (HIF1a, HIF-2a) was increased using adenoviral infection, or reduced by using a dominant-negative mutant, the extent of neointima formation was reduced in the dominant negative mutant mice, and this was associated with decreased expression of several established HIF-target genes, including VEGF-A and its receptors Flt-1 and Flk-1. In contrast, the local overexpression of HIF-1a and HIF-2a was associated with a further increase in the injury-induced neointima formation. 136 The HIF-1 is detectable in the nuclei of ECs covering murine and human atherosclerotic lesions. When the HIF-1a gene was specifically deleted in the ECs from ApoE knockout mice (EC-HIF-1a (À/À) ), the degree of atherosclerotic lesions, the lesional content of macrophages, and the expression of CXCL1 (responsible for the accumulation of macrophages in the atherosclerotic lesion) in ECs were all reduced in the lesions produced by partial ligation of the carotid artery or in the aorta following diet-induced atherosclerosis in EC-HIF-1a (À/À) compared with control mice. In parallel in vitro studies, it was reported that mildly ox-LDL or lysophosphatidic acid 20:4 increased endothelial CXCL1 expression and monocyte adhesion in the atherogenic lesion via the induction of HIF-1. In the mice with endothelial HIF-1a deficiency, there was a downregulation of the micro RNA miR-19a, which controls endothelial function and neovascularization; and HIF-1-induced miR-19a expression that mediated the upregulation of CXCL1 in mildly ox-LDL-stimulated ECs. 137 The HIF-1 has also been reported to attenuate the inflammatory response by regulating T-cell activation and cytokine production. When HIF-1a was overexpressed in ApoE knockout murine lymphocytes, antibody array analysis revealed a pattern consistent with a shift in the cytokine translation pattern from a T helper 1 to T helper 2 phenotype. Normally, the mice in this model develop atherosclerotic lesions within the aortic sinus and these lesions were reduced in the mice with T cells overexpressing HIF-1a. These findings were associated with a reduced expression of interferon g (IFN-g) in CD4
þ spleenderived lymphocytes and aortae of these mice representing a novel immune-modulatory approach in atherosclerosis. 138 It has been also reported that HIF-1 expression is upregulated in CD11c(þ) APCs within atherosclerotic plaques of LDL receptor-deficient (Ldlr (À/À) ) mice and that conditional deletion of HIF-1a in CD11c(þ) APCs in high-fat diet-fed Ldlr (À/À) mice increased the formation of atherosclerotic plaques and increased lesional T-cell infiltration. This suggests HIF-1 has a protective role during atherogenesis. It was further reported that HIF-1 directly modulates STAT3. A reduction in STAT3 expression was found in HIF1-deficient APCs and aortic tissue, together with an upregulated IL-12 expression and expansion of type 1 T-helper (Th1) cells. Overexpression of STAT3 in bone marrow cells of HIF-1a-deficient APCs reversed the enhanced atherosclerotic lesion formation and reduced Th1 cell expansion in chimeric Ldlr (À/À) mice. Furthermore, deletion of HIF-1a in the lysine motif, LysM(þ) bone marrow cells (the most prominent motif for binding to peptidoglycans) in Ldlr (À/À) mice, did not affect lesion formation or T-cell activation. In human atherosclerotic lesions, HIF-1, STAT3, and IL-12 protein were found to colocalize with APCs. The HIF-1 therefore appears to inhibit APC activation and Th1 T-cell polarization in Ldlr (À/À) mice and to attenuate the progression of atherosclerosis. 139 Vascular injury can be induced by placement of an external vascular polyethylene cuff, which is associated with the formation of a neointima. 140 When this model of vascular injury was used in HIF-1-(T-cell)-deficient mice, there was an enhanced neointimal response in the mutant mice and significantly greater infiltration of inflammatory cells into the adventitia. The authors suggest that the mechanism of augmented vascular remodeling in the mutant mice appeared to be due to enhanced production of cytokines by activated T cells and increased antibody production in response to a T-dependent antigen in the mutant mice. 141 Using an ex vivo rat tail artery model maintained for 4 days in hypoxic or normoxic culture and then assessed for contractility, oxygen consumption, and lactate production in oxygenated medium, hypoxia was found to be associated with depressed basal energy turnover, impaired mitochondrial capacity, and altered Ca 2þ homeostasis, but did not affect contractile energetics. 142 Intermittent hypoxia. As discussed earlier in the review, IH is a feature of OSA and is associated with increased cardiovascular mortality and pulmonary hypertension. This may be attributable either to more extensive lesions or lesions that are more unstable in patients with OSA. In a murine model of IH, using a quantitative proteomic method showed that a total of 163 proteins were identified as having changed significantly, of which 34 showed significant differences between genders, and which may be related to vascular injury induced by chronic IH. Twenty upregulated proteins and 14 downregulated proteins were observed in female mice compared to male mice. 143 When ApoE-deficient (ApoE (À/À) ) mice were fed on a highcholesterol (HC) diet, and then subjected to IH for up to 12 weeks, it was reported that at 4 weeks that IH was associated with an increased plaque size in the aortic sinus and the descending aorta. At 12 weeks, atherosclerosis progressed in all groups, but more rapidly in the descending aorta of the IHexposed animals. Plaque composition was similar between IH and controls. In the mice exposed to IH, blood pressure rose with time compared to the mice kept in normoxia, and there were relatively stable increases in serum lipids and arterial stiffness. 144 Intermittent hypoxia may cause endothelial dysfunction in part by the local increase in ROS and reduction of the peripheral repair capacity. This is supported by the finding that antiinflammatory infliximab and antioxidant L-glutathione prevent hypoxia-induced vascular and extravascular changes. 145 The hormone adiponectin has been reported to have antiatherosclerotic properties. Severe obstructive sleep apneahypopnea syndrome is associated with hypoadiponectinemia and a nocturnal reduction in circulating adiponectin concentrations. Exposure of mice to 3 weeks of sustained hypoxia (10% O 2 ) resulted in a significant accumulation of adiponectin in the pulmonary arteries. Pulmonary arterial wall remodeling was found to be greater in adiponectin-knockout mice than wildtype mice under hypoxia. Overexpression of adiponectin was associated with significantly decreased hypoxia-induced pulmonary arterial wall thickening and right ventricular hypertrophy. 146 In rats exposed to IH for 8 h/d, for 5 weeks, cardiac dysfunction was induced as measured by echocardiograph. Adiponectin treatment was associated with amelioration in these indices of cardiac dysfunction and also reduced expressed proteins associated with ER stress as well as the expression of ROS. 147 The ApoE-KO mice and mice deficient in both ApoE and p50 genes (ApoE-p50-DKO) were exposed to IH or sham conditions. Intermittent hypoxia caused atherosclerosis in ApoE-KO mice fed on a normal chow diet in a time-dependent manner. Intermittent hypoxia caused more severe atherosclerotic lesions in the ApoE-p50-double KO (DKO) mice on a normal chow diet. The ApoE-KO and ApoE-p50-DKO mice exposed to IH for 30 and 9 weeks, respectively, displayed similar areas of atherosclerotic lesions on cross sections of aortic root. The P50 gene deletion (in ApoE-p50-DKO mice) significantly augmented IH-induced serum levels of tumor necrosis factor a and IL-6, aortic tumor necrosis factor a, and inducible NOS expression, and aortic infiltration of Mac3-positive macrophages (a marker of proliferation). Intermittent hypoxia caused a greater elevation in serum cholesterol concentrations in ApoE-p50-DKO than in ApoE-KO mice. Intermittent hypoxia was found to be associated with a downregulation of hepatic LDL receptor and HMG-CoA reductase expression in the ApoE-p50-DKO but not in ApoE-KO mice. The NF-kB p50 appeared to protect against IH-induced atherosclerosis by inhibiting vascular inflammation and hypercholesterolemia. 148 In male ApoE-deficient mice subjected to intermittent hypobaric hypoxia (IHH) for 8 weeks for 8 hours a day, plasma lipid levels and plaque size did not differ from control mice. However, the IHH-treated mice exhibited significantly decreased plaque collagen content and increased MMP-9 protein expression, both features of atherosclerotic plaque instability. Tissue inhibitor of MMP (TIMP) 2 expression was decreased after exposure to IHH. Hence, IHH may promote atherosclerotic plaque instability in ApoE-deficient mice by changing the balance of MMPs and TIMPs. 149 In order to explore the early impact of IH on endothelial function and atherogenesis, ApoE À/À mice were exposed to a 6-week-IH either immediately (early pre-atherosclerosis) or after 5 weeks of HC diet (advanced pre-atherosclerosis), with mice maintained under normoxia serving as controls. Endothelial function was assessed ex vivo. Flow cytometry was used to assess blood plasma CD31þ/annexin Vþ endothelial microparticles as well as sca1/flk1þ EPCs in blood and bone marrow. Intermittent hypoxia was found to cause impaired endothelial function and integrity. Peripheral repair capacity expressed as the number of EPCs in blood was attenuated under IH, despite the elevated number of these cells in the bone marrow. In contrast, endothelial function as well as microparticle and EPC levels were similar under IH versus control in more advanced preatherosclerosis. 150 When ECs were cocultured with lymphocytes isolated from rats that had been subjected to either IH or normal conditions, there was a significant decrease in apoptosis regulators, Bcl-2 level, and the Bcl-2/Bax ratio and a significant increase in apoptosis as assessed by Bax and caspase-3 and an increase in measures of oxidative stress (MDA, SOD, and CAT) and inflammation (TNF-a, IL-8, CRP, and ICAM-1). These effects were partially restored by pretreatment with tempol (a membrane permeable-free radical scavenger) and exacerbated by intermittent hypoxic coincubation. 151 Supplementation with the n-3 polyunsaturated fatty acid, docosahexanoic acid, which has anti-inflammatory properties, prevented IH-induced atherosclerosis acceleration in ApoE À/À mice. This was associated with a decrease in aortic MMP-2 gene expression.
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Miscellaneous hypoxia-related studies in murine models. Although advanced murine and human plaques are hypoxic, it is unclear whether plaque hypoxia is causally related to atherogenesis. It is possible to partially ameliorate the hypoxia in atherosclerotic plaques by breathing hyperoxic carbogen gas. The LDL receptor-deficient mice (LDLR À/À ), fed on a Western-type diet, were treated with carbogen (95% O 2 , 5% CO 2 ) or air, and the effect on plaque hypoxia size and phenotype was studied. Pimonidazole was used as an indicator of tissue hypoxia. Carbogen increased arterial blood pO 2 5-fold and reduced plaque hypoxia in advanced plaques of the aortic root and arch. The effect of repeated carbogen exposure on atherosclerosis in LDLR À/À mice fed on a Western-type diet included, a reduction in plaque hypoxia (-40%), necrotic core size (-37%), and terminal uridine nick-end labeling positive apoptotic cell content (À50%) and increased efferocytosis of apoptotic cells by cluster of differentiation 107bþ (CD107b, MAC3) macrophages (þ36%) in advanced plaques of the aortic root. Plaque size, plasma cholesterol, hematopoiesis, and systemic inflammation were unchanged. In vitro, hypoxia hampered efferocytosis by bone marrow-derived macrophages. 153 Following a myocardial infarction, there is a mobilization of EPCs from the bone marrow. This appears to be affected by the circadian gene period2 (per2) that is known to regulate the function of EPCs. Flow cytometry revealed a decreased number of circulating EPCs in per2 (À/À) mice after MI. In vitro, per2 (À/À) EPCs showed decreased migration and tube formation capacity under hypoxia. Western blot analysis revealed that there was an inhibition in the activation of ERK and Akt signaling in the bone marrow of per2 (À/À) mice and inhibited PI3K/Akt expression in per2 (À/À) EPCs under hypoxia. 154 A number of microRNAs function as tissue protective factors in ischemia-reperfusion (I/R) and/or hypoxia-reperfusion (H/R)-induced myocardial injury. The miR-21 has an antiapoptotic role in I/R-induced myocardial damage in vivo and in H/ R-induced H9C2 cell death in vitro. Increased expression of miR-21 upregulates Akt signaling activity by suppressing the expression of phosphatase and tensin homolog (PTEN, an Akt negative regulator), and the increased activity of Akt signaling further inhibits apoptosis partially by increasing the ratio of Bcl-2/Bcl-2-associated X protein, which further suppressed the expression of caspase-3. Hence, miR-21 has a protective role in I/R-and H/R-induced cardiocyte apoptosis via the PTEN/Aktdependent mechanism. 155 
Rabbit Models
The presence of hypoxia within atherosclerotic lesions has been confirmed using 7-(4 0 -(2-nitroimidazole-1-yl)-butyl)-theophylline which binds to foam cells in cholesterol-fed rabbits. 24 Removal of the carotid artery adventitia from rabbits can induce the formation of an intimal hyperplastic lesion. In rabbits fed on a normal diet, the size of the lesion (measured as the intimal:medial ratio) was maximal by day 14 and thereafter regressed toward control dimensions by day 28. In rabbits fed on a HC diet, the lesion was again maximal by day 14. Although some regression was seen, the lesion persisted to day 42. The authors proposed that lesion formation may be initiated following the development of arterial wall hypoxia, secondary to excision of the adventitial vasa vasorum. 156 Microangiogenesis in the arterial wall has been observed during the development and progression of atherosclerosis. The interrelationship between inflammation, oxidative stress, and hypoxia has been investigated with respect to the process of early atherosclerotic microangiogenesis in the cholesterol-fed rabbit. The microvessel density (MVD) in the HC group was significantly higher (P < .01) than that observed in the normocholesterolemic rabbits. Although HIF-1a levels did not change significantly in either of the 2 groups, the levels of inflammatory markers and antioxidants were significantly different between the 2 groups (P < .05). These results suggest that during the initial stages of the hyperlipidemia-induced atherosclerosis, microangiogenesis may be associated with an increase in inflammation and a decrease in the levels of antioxidants, which promote this process even before any tissue hypoxia is detected. 1 Ex vivo, organ bath experiments show that segments of aortae from control, cholesterol-fed, or WHHL rabbits have substantially different responses when the experiments were conducted in hypoxic versus normoxic conditions. These experiments looked at responses to aggregating platelets, 5-hydroxytryptamine (serotonin; 5-HT), norepinephrine, ET, and PG F2a. The contractions under hypoxic conditions in the atherosclerotic rings were not dependent on the presence of an intact endothelium as they could not be antagonized by blockers of a-adrenoceptors, 5-HT2 receptors, histamine receptors, thromboxane receptors, and muscarinic cholinoreceptors. Inhibitors of COX, lipoxygenase, Naþ, Kþ-ATPase, and free-radical scavengers or an activator of endotheliumderived relaxing factor did not significantly affect the hypoxic contraction. The absence of effect of several inhibitors of protein synthesis appears to rule out the involvement of ET, ANG II, and bradykinin. The contraction under hypoxic conditions was not influenced by the omission of Ca 2þ from the medium or by inhibition of Ca 2þ influx but was prevented by blockade of intracellular Ca 2þ . The inhibitors of NOS (nitro-L-arginine, 100 mmol/L) and the guanylyl cyclase (methylene blue, 10 mmol/L) both enhanced the initial contractile responses to 5-HT to a similar extent as hypoxia and completely prevented the hypoxic contraction in the atherosclerotic tissues. Hypoxia decreased cGMP but not the cAMP levels in atherosclerotic aortae with and without endothelium. These data indicate that there are unusual vasoconstrictor responses in atherosclerotic arteries; this constrictor response depends on the availability of intracellular Ca 2þ and seems to be due to the further inhibition of an already impaired cGMP production, most likely due to inhibition of NOS present in non-ECs of the atherosclerotic blood vessels. 157 Balloon injury in the iliac-femoral arteries of hypercholesterolemic rabbits fed with a 0.5% cholesterol diet or a conventional diet was used as a model of atherosclerosis in which macrophage-rich or a SMC-rich neointima was created. Several metabolites of the glycolytic and pentose phosphate pathways (an alternative route of glucose catabolism) were found to be increased, and the tricarboxylic acid (TCA) cycle in the iliac-femoral arteries with macrophagerich neointima, compared with those that were not injured and those with SMC-rich neointima. Pimonidazole immunoreactivity was closely localized with the nuclear translocation of HIF-1a and hexokinase II expression in macrophage-rich neointima. In vitro, THP-1 macrophages stimulated with LPS and IFN-g were cultured under normoxic and hypoxic conditions. The levels of glycolytic and pentose phosphate pathway (4 of 6) metabolites increased in LPS and IFN-g stimulated macrophages under hypoxic but not normoxic condition. 158 Although it has been reported that hypoxia increases and hyperoxia reduces experimental atherosclerosis, it is unclear if repetitive hypoxic and hyperoxic insults affect intimal thickening after arterial injury. In a rabbit model of intermittent repetitive hypoxia or hyperoxia, hypoxia markedly increased the intima-to-media ratio in the abdominal aorta (AA), whereas hyperoxia had no effect on AA disease but increased intimal thickening in thoracic aorta (TA). Hyperoxia promoted positive arterial re-modeling in both TA and AA, resulting in larger luminal size. The cholesterol content in AA was increased by hypoxia and decreased by hyperoxia, but decreased by both treatments in TA. Lipophilic antioxidants and the proportion of arterial lipids that was oxidized were not altered by either hypoxia or hyperoxia. Hence, intermittent repetitive hyperoxia is not protective but promotes arterial disease in normal and injured arteries independent of lipid peroxidation. 159 
Porcine Models
In Yucatan miniature pigs, the oxygenation profiles across the superficial femoral arteries has suggested a relatively poorly oxygenated media (a trough value of approximately 25% of the intimal oxygenation has been reported) with a progressive rise in oxygenation toward the intimal and adventitial surfaces. The vasa vasorum are required to supply the outer media with oxygen, and occlusion of the adventitial vasa vasorum by flush ligation of the arterial branches that supply them resulted in a focal, intimal hyperplastic lesion, composed predominantly of smooth muscle cells which have migrated from the media or was a product of some migration that resulted in proliferation-a process initiated by hypoxia. 21 Coronary arteries also contain a network of adventitial vasa vasorum. These have been visualized in the cholesterol-fed pig, using a novel computed tomography technique. Two different types of vasa vasorum were defined, namely, first-order vasa vasorum ran longitudinally parallel to the vessel and secondorder originated from first-order vasa vasorum circumferentially around the vessel wall. In the hypercholesterolemic coronary arteries, there was a significant increase in the area of the vessel wall and in the density of vasa vasorum. The latter occurred especially by an increase of second-order vasa vasorum and was associated with a loss of the normal spatial pattern. Hence adventitial neovascularization of the vasa vasorum occurs in experimental hypercholesterolemic coronary arteries before the development of vascular lesion. This occurs particularly by an increase in second-order vasa vasorum and a loss of orientation of the normal vasa vasorum pattern, which may be a part of the early atherosclerotic remodeling process. 160 
Ex Vivo Human Studies
Markers of hypoxia and inflammation have been previously identified by microarray analysis in atherosclerotic carotid arteries with low to moderate stenosis. A notable overexpression of HIF-1a in inflammatory and hypoxic areas of carotid arteries in all types of lesions (type II-V lesions) taken from patients with carotid stenosis of < 50% was found. 161 Heat shock proteins (HSPs) are molecular chaperones which are essential for cell survival. 162 Hypoxia was reported to markedly increase the expression of several HSPs in human saphenous vein and the internal mammary artery from patients undergoing coronary artery bypass surgery. A 6-hour period of oxygen deprivation resulted in elevated levels of HSP60, HSP72, and HSP73 in the saphenous vein. In the internal mammary artery, HSP73 expression was found to be significantly enhanced. 163 The precise cellular and molecular mechanisms regulating adventitial vasa vasorum neovascularization, which occurs in the pulmonary arterial circulation in response to hypoxia, remain unknown. In the vessel wall, ECs and mural cells, including fibroblasts, pericytes, and smooth muscle cells, make physical cell-cell contacts, suggesting a role for intracellular communication in the regulation of vascular growth and function. The cell-cell communication between ECs and non-ECs may represent a critical process in the initiation, stabilization, and maturation of new vessels. Adventitial fibroblasts (AdvFBs) and vasa vasorum endothelial cells (VVECs) were isolated from the adventitia of pulmonary arteries. Hypoxiaactivated pulmonary artery AdvFBs exhibited proangiogenic properties and influenced the angiogenic phenotype of the VVEC, in a process involving ET-1, a proangiogenic regulator of neovascularization in many pathological conditions. The AdvFBs, either in experiments using coculture or conditioned media, stimulated VVEC proliferation or augmented the selfassembly and integrity of cord-like networks that formed when VVECs where cultured on Matrigel. When cocultured on Matrigel, AdvFBs and VVECs self-assembled into heterotypic cord-like networks, a process augmented by hypoxia but attenuated by either selective ET receptor antagonists or oligonucleotides targeting prepro-ET-1 mRNA. Hence hypoxiaactivated AdvFBs exhibit proangiogenic properties and communicate with VVECs, in a process involving ET-1, to regulate vasa vasorum neovascularization occurring in the adventitia of pulmonary arteries in response to chronic hypoxia. 164 Increased HIF-1a expression is observed in human atherosclerotic plaque with different phenotypes. The expression of HIF-1a appears to be associated with the presence of a large extracellular lipid core and macrophages and colocalizes with VEGF. The HIF-1a is also associated with an inflammatory phenotype and with VEGF expression. The HIF-1a expression is upregulated in activated macrophages under normoxic conditions suggesting that plaque (immune) inflammatory reactions might also be involved in plaque HIF-1a expression. 165 Intraplaque angiogenesis is a typical feature of hypoxic tissue and expression of HIF. Sluimer et al have demonstrated the presence of hypoxia in human advanced atherosclerotic lesions. Hypoxia was assessed by infusing pimonidazole before carotid endarterectomy. The mRNA and protein expression of HIF-1a, HIF-2a, HIF-responsive genes (VEGF, GLUT1, GLUT3, hexokinase [HK]1, and HK2), and MVD were determined in a series of nondiseased and atherosclerotic carotid arteries using microarray, quantitative reverse transcription PCR, in situ hybridization, and immunohistochemistry. Pimonidazole immunohistochemistry showed hypoxia was particularly present within the macrophage-rich core of the lesions and correlated with the presence of angiogenesis, thrombus formation, and expression of CD68, HIF, and VEGF. The mRNA and protein expression of HIF, its target genes, and MVD increased from early to stable lesions, but no changes were observed between stable and ruptured lesions. The HIF pathway was associated with lesion progression and angiogenesis, suggesting its involvement in the response to hypoxia and the regulation of human intra-plaque angiogenesis. 166 Obstructive sleep apnea is known to be a risk factor for coronary heart disease. Peripheral blood was taken from adults with suspected OSA, and mRNA was prepared from the isolated monocytes for the analysis of C-C chemokine receptor 2 (CCR2-a chemokine that mediates monocyte chemotaxis). Monocytic CCR2 gene expression was found to be increased in patients with severe OSA, and higher levels were detected after sleep. In vitro experiments showed that IH increased the CCR2 expression in THP-1 monocytic cells even in the presence of TNF-a and CRP and also promoted the monocyte chemotactic protein 1-mediated chemotaxis and adhesion of monocytes to ECs. Both ERK and p38 MAPK were confirmed to be involved in the signaling pathway for the induction of CCR2 in monocytes by IH. These results strongly suggest an important role of CCR2 in atherosclerosis in patients with OSA. 167 Neuroimmune guidance cue netrin-1 (Ntn1), initially characterized in the specialized migration of neurons during development, has also been found to inhibit macrophage migration from atherosclerotic plaques and hence enhances chronic inflammation. Netrin-1 and its receptor uncoordinated-5-B receptor (Unc5b) are expressed in macrophages in hypoxic regions of human and mouse plaques. The Ntn1 and Unc5b mRNA are also upregulated in macrophages treated with ox-LDL or inducers of oxidative stress, including hypoxia. These responses are abrogated by inhibiting HIF-1a, indicating a causal role for this transcription factor in regulating Ntn1 and Unc5b expression in macrophages. The J774 macrophages overexpressing active HIF-1a express increased levels of netrin-1 and Unc5b and have a reduced migratory capacity compared with control cells. This can be restored by blocking the effects of netrin-1. Netrin-1 protects macrophages from apoptosis under hypoxic conditions in a HIF-1a-dependent manner via regulating macrophage trafficking and accumulation during hypoxia in atherosclerosis. Therefore, HIF-1a regulation of netrin-1 is involved in promoting macrophage accumulation and survival in atherosclerotic plaque and provides further evidence of a role for hypoxia in sustaining inflammation. Local inhibition of such factors may have a therapeutic value for the resolution of inflammation in atherosclerosis and other chronic inflammatory disease. 168, 169 A high proportion of stable plaques have been reported to have neovascularization. Regional expression of hypoxia-and thioredoxin-related genes in different parts of stable atherosclerotic carotid plaques has been investigated. The expressions of HIF-la, VEGF-A, thioredoxin, and thioredoxin-interacting protein were analyzed in carotid endarterectomy samples using RT-PCR on laser microdissected regions. The expression of all 4 genes was significantly lower in the medial region at the mRNA level. High expression of these genes was noted in the shoulder region and sites of neovascularization, with no significant difference between the 2, and these expression patterns were related to macrophage infiltration. Hypoxia-and thioredoxin-related genes are significantly overexpressed in human stable carotid atherosclerotic plaques and strongly correlate with macrophage infiltration rather than neovascularization. Macrophage infiltration may lead to overexpression of these genes providing a mechanism of transcriptional activation of several other target genes contributing to angiogenesis, atherosclerotic progression, and vascular remodeling in stable carotid plaques. 170 Plaque hemorrhage in carotid atherosclerosis may promote plaque progression and rupture that may result in cerebrovascular disease. The HIF-1a induces angiogenesis via the expression of VEGF and E26 transformation-specific-1 (Ets-1). A higher incidence of plaque hemorrhage is observed in plaques associated with symptoms than in those without. The expression of HIF-1a, VEGF, and Ets-1 is colocated in the deep layer of plaque, where angiogenesis is also well developed. Symptomatic plaques were found to have a higher expression of VEGF than asymptomatic plaques. Plaques with hemorrhage were associated with a higher incidence of plaque ulceration and higher expression of Ets-1 than those without hemorrhage. Significantly higher expression levels of VEGF and Ets-1 were observed in plaques with hemorrhages, ulcers, and severe stenosis. Hypoxia-inducible angiogenic proteins in human carotid atherosclerosis therefore appear to promote intraplaque angiogenesis, which can induce plaque hemorrhage and progression. 171 
Genetic Determinants of the Response to Hypoxia
Patients with chronic ischemic heart disease develop coronary artery collaterals (new vessels) due to myocardial hypoxia. However, there is a marked variability in the tendency to develop these collaterals. Although this variability is likely to be multifactorial, genetic factors are thought to be involved. Genetic variations in HIF-1a have been reported to influence the development of coronary artery collaterals in patients with significant coronary artery disease. 172 They have also been reported as predisposing to abdominal aortic aneurysm. 173 
Conclusion
There is now substantial evidence that there are areas of profound hypoxia within atherosclerotic lesions. There is also good evidence that hypoxic states, such as that associated with OSA, may be involved in the etiology of cardiovascular disease. The HIF-1 appears to be an important mediator of the proatherogenic cellular response to hypoxia. Hypoxia has important effects on intermediary metabolism, cholesterol disposal, and the inflammatory response within the artery wall. It also appears to promote changes in the cellular and extracellular composition of the artery wall that may impact on the response to injury.
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